Leaving, Coming, and Staying HIV Obligate Microenvironments (HOME)
Project Number5P01AI169609-02
Contact PI/Project LeaderSMITH, DAVID MITCHELL
Awardee OrganizationUNIVERSITY OF CALIFORNIA, SAN DIEGO
Description
Abstract Text
OVERALL: Leaving, Coming, and Staying HIV Obligate Microenvironments (HOME)
ABSTRACT
Viral, host and environmental mechanisms governing HIV reservoir dynamics on and off antiretroviral therapy
(ART) must be grasped more deeply if cure efforts are to be successful. Further, variability in the size, distribution
and activity of the reservoir is substantial, and although a ‘one size fit all’ HIV cure strategy is seducing, a
reductionist ‘bulk’ approach cannot fully capture the complex underlying processes of HIV reservoir dynamics.
To better define the viral, host and environmental factors that govern these dynamics at the cellular and single-
genome level, our novel Leaving, Coming and Staying HIV Obligate MicroEnvironments (HOME) program
builds on our previous infrastructure, and success, including our ‘Last Gift’ cohort, which enrolls altruistic people
with HIV (PWH) who did or did not stop ART before death, collects pre-mortem clinical data and limited samples,
then performs a full body rapid autopsy with sample collection across the body within 6 hours of death. The
rationale for our program is that the use of new single-cell and single-genome technologies will bring new
perspectives on assumptions built on bulk technologies and help identify vulnerabilities in HIV reservoir states:
• Leaves HOME when HIV (re)activates from tissues during ART (i.e., ‘ready to move once ART is interrupted’,
like packing its bag and getting ready to leave) and causes rebound viremia during ART interruption.
• Comes HOME when HIV (re)populates tissues during viremia off ART and through the spread of clonally
expanded HIV-infected cells while on ART. (Clonal expansion is like adding family to the home.)
• Stays HOME when HIV persists in tissue reservoirs during ART and viral suppression in plasma.
The HOME program is organized into three Research Projects (RP) to investigate these reservoir dynamics:
• The Viral, EpigeNetics and Integration (VENI) RP will investigate viral and proviral epigenetic factors.
• The Viral, Immunology, Drugs, and Imaging (VIDI) RP will investigate host and environmental factors.
• The Viral, Immune, and Cellular data Integration (VICI) RP will develop new methods needed for the
integration and analysis of complex multi-dimensional data.
These three RPs will be supported by two cores: the Administrative and Data (AD) Core will provide leadership,
communication and data services, and the Clinical, Outreach, Pathology and Ethics (COPE) Core will direct and
ethically oversee the Last Gift cohort.
Our proposed HOME program is a good use of resources because it innovatively responds directly to the
Understanding HIV Reservoir Dynamics RFA (AI-21-013) and will create the next level of understanding of deep
HIV reservoirs. We expect to clearly define the viral, immunological, cellular expression, epigenetic, tissue
architectural factors associated with specified HIV reservoir states across the human body on and off ART. Such
results would be foundational for HIV cure strategies aimed at locking down or clearing HIV reservoirs.
Public Health Relevance Statement
NARRATIVE
Our HOME program is designed to be directly responsive to the Understanding HIV Reservoir Dynamics RFA
(RFA-AI-21-013) to define how HIV colonizes, establishes, and moves within and across reservoirs with different
immune, cell, epigenetic and HIV drug environments. This program will provide new knowledge on the
fundamental viral and host mechanisms driving HIV reservoir dynamics and identify the vulnerabilities in the
activity and renewal of HIV reservoirs across the human body that can be targeted by new HV cure efforts.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
804355790
UEI
UYTTZT6G9DT1
Project Start Date
01-April-2022
Project End Date
31-March-2027
Budget Start Date
01-April-2023
Budget End Date
31-March-2024
Project Funding Information for 2023
Total Funding
$2,594,658
Direct Costs
$1,816,194
Indirect Costs
$778,464
Year
Funding IC
FY Total Cost by IC
2023
National Institute of Allergy and Infectious Diseases
$2,594,658
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P01AI169609-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P01AI169609-02
Patents
No Patents information available for 5P01AI169609-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P01AI169609-02
Clinical Studies
No Clinical Studies information available for 5P01AI169609-02
News and More
Related News Releases
No news release information available for 5P01AI169609-02
History
No Historical information available for 5P01AI169609-02
Similar Projects
No Similar Projects information available for 5P01AI169609-02